rs34070318

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016507.4(CDK12):​c.3824C>T​(p.Pro1275Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0153 in 1,612,074 control chromosomes in the GnomAD database, including 267 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1275P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.011 ( 14 hom., cov: 32)
Exomes 𝑓: 0.016 ( 253 hom. )

Consequence

CDK12
NM_016507.4 missense

Scores

9
9

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 2.35

Publications

19 publications found
Variant links:
Genes affected
CDK12 (HGNC:24224): (cyclin dependent kinase 12) Enables RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin binding activity. Involved in phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; and regulation of MAP kinase activity. Located in nuclear speck. Part of cyclin K-CDK12 complex. [provided by Alliance of Genome Resources, Apr 2022]
CDK12 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006244242).
BP6
Variant 17-39530667-C-T is Benign according to our data. Variant chr17-39530667-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 133863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0108 (1644/152096) while in subpopulation NFE AF = 0.0163 (1107/67994). AF 95% confidence interval is 0.0155. There are 14 homozygotes in GnomAd4. There are 781 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK12NM_016507.4 linkc.3824C>T p.Pro1275Leu missense_variant Exon 14 of 14 ENST00000447079.6 NP_057591.2 Q9NYV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK12ENST00000447079.6 linkc.3824C>T p.Pro1275Leu missense_variant Exon 14 of 14 1 NM_016507.4 ENSP00000398880.4 Q9NYV4-1
CDK12ENST00000430627.6 linkc.3797C>T p.Pro1266Leu missense_variant Exon 14 of 14 1 ENSP00000407720.2 Q9NYV4-2
CDK12ENST00000584336.1 linkn.786C>T non_coding_transcript_exon_variant Exon 1 of 1 6
CDK12ENST00000559663.2 linkn.3760+4351C>T intron_variant Intron 13 of 20 5 ENSP00000453329.2 H0YLT2

Frequencies

GnomAD3 genomes
AF:
0.0108
AC:
1644
AN:
151978
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00305
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00617
Gnomad ASJ
AF:
0.0228
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00332
Gnomad FIN
AF:
0.0184
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0163
Gnomad OTH
AF:
0.0116
GnomAD2 exomes
AF:
0.0116
AC:
2886
AN:
248522
AF XY:
0.0120
show subpopulations
Gnomad AFR exome
AF:
0.00258
Gnomad AMR exome
AF:
0.00385
Gnomad ASJ exome
AF:
0.0237
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0175
Gnomad NFE exome
AF:
0.0171
Gnomad OTH exome
AF:
0.0101
GnomAD4 exome
AF:
0.0158
AC:
23008
AN:
1459978
Hom.:
253
Cov.:
34
AF XY:
0.0153
AC XY:
11144
AN XY:
726124
show subpopulations
African (AFR)
AF:
0.00212
AC:
71
AN:
33450
American (AMR)
AF:
0.00414
AC:
185
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.0238
AC:
621
AN:
26044
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39666
South Asian (SAS)
AF:
0.00495
AC:
426
AN:
86140
European-Finnish (FIN)
AF:
0.0166
AC:
885
AN:
53298
Middle Eastern (MID)
AF:
0.00522
AC:
30
AN:
5750
European-Non Finnish (NFE)
AF:
0.0179
AC:
19893
AN:
1110664
Other (OTH)
AF:
0.0148
AC:
895
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1235
2470
3706
4941
6176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0108
AC:
1644
AN:
152096
Hom.:
14
Cov.:
32
AF XY:
0.0105
AC XY:
781
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.00304
AC:
126
AN:
41482
American (AMR)
AF:
0.00616
AC:
94
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.0228
AC:
79
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00353
AC:
17
AN:
4812
European-Finnish (FIN)
AF:
0.0184
AC:
195
AN:
10600
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.0163
AC:
1107
AN:
67994
Other (OTH)
AF:
0.0114
AC:
24
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
80
160
239
319
399
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0137
Hom.:
27
Bravo
AF:
0.00983
TwinsUK
AF:
0.0170
AC:
63
ALSPAC
AF:
0.0138
AC:
53
ESP6500AA
AF:
0.00341
AC:
15
ESP6500EA
AF:
0.0166
AC:
143
ExAC
AF:
0.0116
AC:
1409
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0136
EpiControl
AF:
0.0168

ClinVar

Significance: Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

CDK12-related disorder Benign:1
Jun 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.057
.;T
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.88
D;D
MetaRNN
Benign
0.0062
T;T
MetaSVM
Uncertain
-0.20
T
MutationAssessor
Benign
1.5
.;L
PhyloP100
2.4
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-2.7
D;N
REVEL
Benign
0.26
Sift
Benign
0.14
T;T
Sift4G
Uncertain
0.0060
D;T
Polyphen
1.0
D;D
Vest4
0.34
MPC
0.20
ClinPred
0.022
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.25
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34070318; hg19: chr17-37686920; COSMIC: COSV71002230; API